Questions? Call 888-624-8373

PAPERBACK
list:$57.00
Web:$51.30
add to cart

PDF BOOK
your price: $44.00
add to cart

Rights & Permissions

topleft topright

Toxicological Effects of Methylmercury (2000)
Commission on Life Sciences (CLS)

Page
326
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Toxicological Effects of Methylmercury

COMMITTEE FINDINGS AND RECOMMENDATIONS

  • Hg is pervasive and persistent in the environment. Its use in products and emission from industrial processes and combustion have resulted in global circulation and atmospheric deposition. There have been well-documented instances of population poisonings, highly exposed occupational groups, and worldwide chronic low-level environmental exposures. The bioaccumulation of MeHg can lead to high concentrations in many species of fish and result in unacceptable levels of exposure and risk to highly exposed or susceptible subpopulations.

  • The weight of the evidence of developmental neurotoxic effects from exposure to MeHg is strong. There is a strong data base, which includes multiple human studies and experimental evidence in animals and in vitro tests. Human studies include both high-exposure scenarios and evaluations of effects of chronic low-level exposure. The epidemiological studies also include well-established biomarkers to evaluate exposure levels in study populations.

  • The weight of evidence from multiple epidemiological studies supports the selection of neurotoxicity in children exposed in utero as the most sensitive well-documented effect and a suitable end point for the derivation of the BMD. However, emerging evidence of other potential effects should also be considered in the calculation and the implementation of the EPA RfD.

  • Given the availability of results from large prospective epidemiological studies, the Iraq study results should no longer be considered the critical study for the EPA RfD. The exposure scenarios in Iraq are not comparable to the low-level chronic exposures in North America. In addition, there are well-recognized uncertainties concerning exposure and response classification in the Iraq study.

  • The New Zealand, Faroe Islands, and Seychelles studies are well-designed epidemiological investigations in which prenatal MeHg exposures were within the range of at least some U.S. population exposures. Any revision of the RfD or other exposure standards should consider the findings of these studies.

  • After considering the weight of evidence and range of results from the three major epidemiological studies, the committee concludes

Page
326